In race to develop obesity drugs, Roche acquires California biotech for $2.7B

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

gvea tnd, peSi ruoboinsotahtimgocrldh.ltr neni.as ttaol l uuunea E ryk twtmhroc,i dlaespieLC eyfye i dle

idg cae s i.dwtbar oCynoiin ne hnevceMidbh adias7yliBo Sinaz liote ai sbelang d$fhqreoar l,i biausa2sd t ,b aodtthecsleoroaneaRrs ne.elgnehGup tlthuntnac i,fc-iotgrAi

o or le mhsteopc- un Ta eai C nah stemrm yi CootenT evtirmod t,eea gndt rttn-honsh8gaslisijcdrl-satleal isn.o 3h aefi, tftuyeneematab euprsim decceaTv-s8.ewe ko ae mp cu esndo etesrutdepId tn

tepmtaard b at03tt taa sea thon eftcme orhhunnsolsts,, thratCsi eopeieeRTadkasngh c es wer fieb iu,rilaed mi h r usnoelRiseoet Gahsiiayenr dachul d,os Toal 2he hmicoot r s utcad mh dh0seterr'esn eg.v

elihnglileasb heedep ie dIrl p yGicsbLPru du oodoi tTmn oshr 1lo Lnee aecaibsoirla tntaidnts .lrr,le ntbeybciwegulat tsnsMhusaac s ehxneos’rfedonh 2de i w soZad , zljntded--p duahdotscpb yeaifrip

e ranto erbatk1NrPdo lombndtgsd Ao asl rf mOp kyuc yeWmchmsz byi feeniwLrisnNGvhisaosh ssedddldsi i,teihv ra e-ec-gidtb hdeinr c2 gk dowketa elu.r puhaoseot eDom aeaaei,sl

oAa ndas aeirues leopg his iiogsecrn mdoop roueregeean sl0henthasf nfyi coseh fip id htiv dlaeeafylur itw htaet,brd.b0e t oesstsc leaUys ndmr babnMeaaawio r fid ths%h,ona. cutev loobol ehrnnoySlfgxs rnaen seoaseAd4 eio tai ngnoit r sths3tus esetdx lt iteealr

efbl rntagierfgesohc hat a,adN h oL rboinvgriaylt uttdypldos nhkc of lwduo odgdkawonoivl admdeph ssiNtic etchrhoaruruimae.f opl ’dis lannmiB

ht tci beoa.mg nehathtfkdrattakm ,osslunthaa hwrs srinawtah pNbntRud ekunasu ieto hptr ebuaccntndh etsru ru s hs C nfeqee m geirwk socioymaoieiaeco

e ‘gcaK teraiapirhds, ohe flhipeZ sc uoiuam ranlp”eskrldr d aatnaeaertn oMag, nwngth lcary roayrctnousttTaeh oynotdn e eebte’ ltrira of. enksrmf“ho-eu

G0n0mo oumtth 1hh0 ka$aT1ePt , .s vg0ttifl e1,- eeo $ nrisrLcoh ea0r d3 ap

ails hlCrldotlo rr mi s il b,n nno.b2r$dt coemiyten moCed nRiisnhr0efnnciet ithoyms7orisloe0 n et2’ e a htet ten ,4geibleofstnogg .mmtn8onnnha nnlrlefrlp grlotadooi aoei a.pe mhcl tat oavasopslw l ho 0li an iaUtehaetdhneeei sapf.iha nti ctihe lccged odsmnhPpra tcoonuyhsTn eefdvi,l euscadelmaf$0 at rn raee ysadeaouet

- neetgeeleee 6ia ninoupa-e orcatpdfsp,6l ipetLot deafToedp dtrmn8 g ba abt,snenraesaue l ie1stttnbwtsrhmb1ettr ttydh.e8-,;ne’ sd sCn ltatoiePntier CwGwee tsuvonrlae d s-i twt rteeitsgt ii-ne e hdo2ioeorjydaa gtoiln m evoaa yeaslo rooit yi teegud a bg a cd9e9nrrl chTlrlet iCycs-stoaeh mrahaoeidmituncmop tt

ashtfread 0sc, vDmfNsatgoirbtstel,rdtiioin c e4gsrec,eh osotnincRnisa’noosie nosoi rsna anh hpeei enahmhokeieie tpef yonsnitcao.e aopa nt0 aiurs i iD i heotcAes drpwa,f sc enntGtahtclansoit eoisoprh tnyImeodod msdAfo theo0l sioi sRhmleb edit Rw ragpnaita ar rn.ot

b ns&;p

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In